Cybin Inc. Common Stock share price logo

Cybin Inc. Common Stock Share Price

NASDAQ: HELP

Small Cap

$5.50

as on

Cybin Inc. Common Stock Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $5.45
    $5.79
    downward going graph

    0.91%

    Downside

    5.27%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Cybin Inc. Common Stock share price movements today

Previous Close
$5.50
Open
$5.66
Volume
1.4M
Day's Low - High
$5.45 - $5.79

Cybin Inc. Common Stock Historical Returns

1 Month Return
+ 13.17 %
3 Month Return
-28.94 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Cybin Inc. Common Stock Stock Fundamentals & Key Indicators

Check Cybin Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$274.4M

EPS (TTM)

-5.2372

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-55.89%

Cybin Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cybin Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Cybin Inc. Common Stock image
Cybin Inc. Common Stock
NA$274.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$42.7B130.51%136.818.45%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$110.8B98.57%28.4232.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$36.8BNA129.845.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$78.9B48.43%17.9831.41%

Cybin Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for Cybin Inc. Common Stock Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-13% versus previous 30 day period

Cybin Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
-
0
0
0
Operating Income
-57
-32
-33
-33
-40
-56
EBITDA
-57
-32
-
-33
-40
-56
Interest Expense
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-56
-10
-30
-33
-47
-58
Income Tax Expense
-
-
-
-
-
-
Net Income
-56
-7
-21
-33
-47
-58
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cybin Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
0
-
-
-
-
Gross Profit
0
0
0
0
0
Operating Income
-31
-63
-51
-78
-143
EBITDA
-30
-63
-51
-78
-142
Interest Expense
0
0
-
-
-
Depreciation
-
0
0
0
0
Income Before Tax
-32
-67
-47
-78
-113
Income Tax Expense
-
-
-
-
-
Net Income
-32
-53
-34
-57
-78
Net Profit Margin
-3729.17%
0.00%
0.00%
0.00%
0.00%

Cybin Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-30
-21
-10
-56
-10
-50
-24
-47
-58
Operating Cash Flow
-26
-20
-19
-25
-26
-21
-29
-48
-43
Investing Cash Flow
7
0
0
0
0
-
0
0
0
Financing Cash Flow
39
190
0
0
0
20
54
0
197
Change in Cash
20
169
-20
-26
-28
-1
24
-48
152

Cybin Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
0
0
0
-32
-67
-47
-78
-113
Operating Cash Flow
0
0
0
-19
-45
-47
-68
-101
Investing Cash Flow
0
0
0
-1
0
-3
6
-1
Financing Cash Flow
0
-
0
82
35
13
254
20
Change in Cash
0
0
0
62
-10
-37
192
-73

Insights on Cybin Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HELP stock has moved up by 13.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 21.1% return, outperforming this stock by 83.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Beone Medicines Ltd has given 38.8% return, outperforming this stock by 64.0%

About Cybin Inc. Common Stock

Cybin Inc., doing business as Helus Pharma, a clinical-stage neuropsychiatry company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions. It develops CYB003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and CYB004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders. The company also develops SPL028 injectable deuterated DMT completed phase 1 clinical intramuscular and intravenous trial; SPL026 for MDD; and CYB005, a phenethylamine derivative, which in preclinical stage to treat central nervous system, as well as has a research pipeline of investigational psychedelic-based compounds. It has a strategic partnership agreement with Segal Trials to support PARADIGM, a multinational pivotal phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder. The company is headquartered in Toronto, Canada.
OrganisationCybin Inc. Common Stock
Headquarters100 King Street West, Toronto, ON, Canada, M5X 1C9
IndustryBiotechnology
CEOMr. Michael F. Cola
E-voting on sharesClick here to vote

Key Management of Cybin Inc. Common Stock

Name

Title

Mr. Michael F. Cola

Chief Executive Officer

Mr. John Kanakis

Co-Founder

Mr. Aaron Bartlone

Chief Operating Officer

Mr. Paul Glavine

Co-Founder, Chief Growth Officer & Director

Mr. Greg Cavers

Chief Financial Officer

Mr. George Tziras

Chief Business Officer

Ms. Lori Challenger

Chief Compliance, Ethics & Administrative Officer

Mr. Eric So L.L.B.

Co-Founder, President & Executive Chairman

Mr. Gabriel Fahel

Chief Legal Officer & Corporate Secretary

Dr. Alex L. Nivorozhkin Ph.D.

Chief Scientific Officer

FAQs

What is Cybin Inc. Common Stock share price today?

Cybin Inc. Common Stock share price today is $5.5 as on at the close of the market. Cybin Inc. Common Stock share today touched a day high of $5.79 and a low of $5.45.

What is the 52 week high and 52 week low for Cybin Inc. Common Stock share?

Cybin Inc. Common Stock share touched a 52 week high of $ on and a 52 week low of $ on . Cybin Inc. Common Stock stock price today i.e. is closed at $5.5,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Cybin Inc. Common Stock's market capitalisation today?

Cybin Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Cybin Inc. Common Stock Stock (HELP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cybin Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cybin Inc. Common Stock Shares that will get you 0.2727 shares as per Cybin Inc. Common Stock share price of $5.5 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Cybin Inc. Common Stock Stock (HELP) from India?

Indian investors can start investing in Cybin Inc. Common Stock (HELP) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in Cybin Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Cybin Inc. Common Stock share’s latest price of $5.5 as on April 18, 2026 at 1:29 am IST, you will get 1.8182 shares of Cybin Inc. Common Stock. Learn more about fractional shares .